Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Angelos

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Scientific Reports|September 14, 2019
Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytesNaresh Kumar, Julie A Dougherty, Heather R Manring, et al.
American Journal of Hematology|February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid LeukemiaMichael K Jones, Jesse Sanchez, Megan Connor, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Scientific Reports|September 14, 2019
Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytesNaresh Kumar, Julie A Dougherty, Heather R Manring, et al.
American Journal of Hematology|February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid LeukemiaMichael K Jones, Jesse Sanchez, Megan Connor, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Pageof 9